Evidence map›Paper›PMID 29720095›Full record

ArticleBMC infectious diseases2018

Addressing knowledge gaps and prevention for tuberculosis-infected Indian adults: a vital part of elimination.

Andrea DeLuca, Gauri Dhumal, Mandar Paradkar, Nishi Suryavanshi, Vidya Mave, Rewa Kohli, Shri Vijay Bala Yogendra Shivakumar, Vidula Hulyolkar, Archana Gaikwad, Ashwini Nangude and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Andrea DeLucaJohns Hopkins Bloomberg School of Public Health, International Health, Baltimore, MD, USA. adeluca@jhu.edu.ORCID 0000-0003-4532-5311
Gauri DhumalByramjee-Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Trials Unit, Pune, India.
Mandar ParadkarByramjee-Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Trials Unit, Pune, India.
Nishi SuryavanshiByramjee-Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Trials Unit, Pune, India.
Vidya MaveByramjee-Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Trials Unit, Pune, India.
Rewa KohliByramjee-Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Trials Unit, Pune, India.
Shri Vijay Bala Yogendra ShivakumarByramjee-Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Trials Unit, Pune, India.
Vidula HulyolkarByramjee-Jeejeebhoy Government Medical College, Pune, India.
Archana GaikwadByramjee-Jeejeebhoy Government Medical College, Pune, India.
Ashwini NangudeByramjee-Jeejeebhoy Government Medical College, Pune, India.
Geeta PardeshiDepartment of Community Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
Dileep KadamByramjee-Jeejeebhoy Government Medical College, Pune, India.
Amita GuptaJohns Hopkins Bloomberg School of Public Health, International Health, Baltimore, MD, USA.
Johns Hopkins University · USGovernment Medical College · INVardhman Mahavir Medical College & Safdarjung Hospital · IN

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
HIV-TB Fogarty Research Training ProgramD43TW009574 · FIC · JOHNS HOPKINS UNIVERSITY · PI BOLLINGER, ROBERT C. · 2013 to 2017
$1.0M
FIC NIH HHS D43 TW009574FIC NIH HHS D43TW009574NIAID NIH HHS P30 AI094189NIH HHS P30AI094189NIH HHS USB1-31147-XX-13
6 · The paper itself

Abstract

backgroundIndia plans to eliminate tuberculosis (TB) by 2025, and has identified screening and prevention as key activities. Household contacts (HHCs) of index TB cases are a high-risk population that would benefit from rapid implementation of these strategies. However, best practices for TB prevention and knowledge gaps among HHCs have not been studied. We evaluated TB knowledge and understanding of prevention among tuberculin skin-test (TST) positive HHCs. While extensive information is available in other high-burden settings regarding TB knowledge gaps, identifying how Indian adult contacts view their transmission risk and prevention options may inform novel screening algorithms and education efforts that will be part of the new elimination plan.

methodsWe approached adult HHC to administer a questionnaire on TB knowledge and understanding of infection. Over 1 year, 100 HHC were enrolled at a tertiary hospital in Pune, India.

resultsThe study population was 61% (n = 61) female, with a mean age of 36.6 years (range 18-67, SD = 12). Education levels were high, with 78 (78%) having at least a high school education, and 23 (24%) had at least some college education. Four (4%) of our participants were HIV-infected. General TB knowledge among HHC was low, with a majority of participants believing that you can get TB from sharing dishes (70%) or touching something that has been coughed on (52%). Understanding of infection was also low, with 42% believing that being skin-test positive means you have disease. To assess readiness for preventive therapy, we asked participants whether they are at a higher risk of progressing to active disease because of their LTBI status. Fifty-four (55%) felt that they are at higher risk. Only 8% had heard of preventive therapy.

conclusionOur TB knowledge survey among HHCs with evidence of recent exposure found that knowledge is poor and families are confused about transmission in the household. It is imperative that the Indian program develop tools and incentives that can be used to educate TB cases and their families on what infected HHCs can do to prevent disease, including preventive therapy.

Indexed as

Health Knowledge, Attitudes, PracticeAdolescentAdultAgedAntitubercular AgentsFamily CharacteristicsFemaleHIV InfectionsHumansIndiaMaleMiddle AgedRisk FactorsSurveys and QuestionnairesTuberculin TestTuberculosisAntitubercular AgentsAccessContactsTuberculosis prophylaxis

Identifiers

PMID29720095
PMCPMC5932769
OpenAlexW2806030607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.